VERTEX PHARMACEUTICALS INC / MA Weighted Avg Shares (Basic) 2008-2026 | VRTX
What is weighted avg shares (basic)?
Weighted average shares outstanding (basic) is the time-weighted average number of common shares outstanding during the reporting period, used as the denominator to calculate basic earnings per share.
What is VERTEX PHARMACEUTICALS INC / MA's current weighted avg shares (basic)?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual weighted avg shares (basic) for 2025 was 255.7M, a 0.85% decline from 2024. VERTEX PHARMACEUTICALS INC / MA weighted avg shares (basic) for the quarter ending March 31, 2026 was 254.1M.
What was VERTEX PHARMACEUTICALS INC / MA's weighted avg shares (basic) in 2024?
VERTEX PHARMACEUTICALS INC / MA annual weighted avg shares (basic) for 2024 was 257.9M, a 0.08% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's weighted avg shares (basic) in 2023?
VERTEX PHARMACEUTICALS INC / MA annual weighted avg shares (basic) for 2023 was 257.7M, a 0.62% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year weighted avg shares (basic) CAGR?
VERTEX PHARMACEUTICALS INC / MA weighted avg shares (basic) grew at a compound annual growth rate (CAGR) of 0.32% from FY2020 to FY2025, going from 259.8M to 255.7M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | 255.7M | -0.9% | 10-K |
| FY2024 | 257.9M | +0.1% | 10-K |
| FY2023 | 257.7M | +0.6% | 10-K |
| FY2022 | 256.1M | -0.6% | 10-K |
| FY2021 | 257.7M | -0.8% | 10-K |
| FY2020 | 259.8M | +1.2% | 10-K |
| FY2019 | 256.7M | +0.9% | 10-K |
| FY2018 | 254.3M | +2.2% | 10-K |
| FY2017 | 248.9M | +1.7% | 10-K |
| FY2016 | 244.7M | +1.4% | 10-K |
| FY2015 | 241.3M | +2.6% | 10-K |
| FY2014 | 235.3M | +4.6% | 10-K |
| FY2013 | 224.9M | +6.1% | 10-K |
| FY2012 | 211.9M | +3.4% | 10-K |
| FY2011 | 204.9M | +2.2% | 10-K |
| FY2010 | 200.4M | +15.7% | 10-K |
| FY2009 | 173.3M | +23.3% | 10-K |
| FY2008 | 140.6M | - | 10-K |